SCHEMBL12653191

SCHEMBL12653191

CCN(CC)C(=O)CN1CC(C)(C)OC[C@H]1C(=O)Nc1cc(I)cc2c1[nH]c1cncc(F)c12

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ICOSLG O75144 1/20 0.35
▸ ICOS Q9Y6W8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12619799 0.91 ICOSLG (0.45) ICOSLGICOS
SCHEMBL12653368 0.81 ICOSLG (0.45) ICOSLGICOS
SCHEMBL1801702 0.78 ICOSLG (0.61) ICOSLGICOS
SCHEMBL12619440 0.78 ICOSLG (0.61) ICOSLGICOS
SCHEMBL12619474 0.78 ICOSLG (0.44) ICOSLGICOS
SCHEMBL12619473 0.78 ICOSLG (0.44) ICOSLGICOS
SCHEMBL12653326 0.77 ICOSLG (0.34) ICOSLGICOS
SCHEMBL12619673 0.77 ICOSLG (0.43) ICOSLGICOS
SCHEMBL1810096 0.76 ICOSLG (0.45) ICOSLGICOS
SCHEMBL13349318 0.75 ICOSLG (0.53) ICOSLGICOS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7951801-B2 For therapy of inflammatory disease and cancer MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-05-31 — — US disclosed
Send feedback